Publications by authors named "Alexander Szubert"

Claim this Profile
P
Pharmacokinetics of lopinavir/ritonavir in second-line treatment of children with HIV in the CHAPAS-4 trial.
Anne E M Kamphuis, Timo Kiezebrink, Hylke Waalewijn, Alasdair Bamford, Alexander J Szubert

AIDS· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV.
Lufina Tsirizani, Hylke Waalewijn, Alexander Szubert, Veronica Mulenga, Chishala Chabala

Antimicrob Agents Chemother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison between dual energy X-ray absorptiometry and calcaneal quantitative ultrasound for determining bone mineral density in children living with HIV in uganda: A cross- sectional study.
Eva Natukunda, Alexander J Szubert, Alasdair Bamford, Katja Doerholt, Diana M Gibb

BMC Pediatr· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic data of atazanavir/ritonavir in second-line treatment of children living with HIV.
Anne E M Kamphuis, Hylke Waalewijn, Roeland E Wasmann, Alasdair Bamford, Alexander Szubert

J Acquir Immune Defic Syndr· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-Line Antiretroviral Therapy for Children Living with HIV in Africa.
Victor Musiime, Mutsa Bwakura-Dangarembizi, Alexander J Szubert, Vivian Mumbiro, Hilda A Mujuru

N Engl J Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Subphenotypes of Staphylococcus aureus Bacteremia.
Maaike C Swets, Zsuzsa Bakk, Annette C Westgeest, Karla Berry, George Cooper, Alexander Szubert

Clin Infect Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIV.
Lufina Tsirizani, Shaghayegh Mohsenian Naghani, Hylke Waalewijn, Alexander Szubert, Veronica Mulenga

J Antimicrob Chemother· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When should factorial designs be used for late-phase randomised controlled trials?
Ian R White, Alexander J Szubert, Babak Choodari-Oskooei, A Sarah Walker, Mahesh Kb Parmar

Clin Trials· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 Trial.
Lisanne A H Bevers, Hylke Waalewijn, Alexander J Szubert, Chishala Chabala, Mutsa Bwakura-Dangarembizi

Clin Infect Dis· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial.
Hylke Waalewijn, Alexander J Szubert, Roeland E Wasmann, Lubbe Wiesner, Chishala Chabala

Clin Infect Dis· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial.
Katrina M Pollock, Hannah M Cheeseman, Alexander J Szubert, Vincenzo Libri, Marta Boffito

EClinicalMedicine· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of viraemia on inflammatory biomarkers and CD4+ cell subpopulations in HIV-infected children in sub-Saharan Africa.
Andrew J Prendergast, Alexander J Szubert, Godfrey Pimundu, Chipo Berejena, Pietro Pala

AIDS· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of recurrence, early treatment failure and death from Staphylococcus aureus bacteraemia: Observational analyses within the ARREST trial.
Alexander Szubert, Sarah Lou Bailey, Graham S Cooke, Tim Peto, Martin J Llewelyn

J Infect· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory biomarkers in HIV-infected children hospitalized for severe malnutrition in Uganda and Zimbabwe.
Andrew J Prendergast, Chipo Berejena, Godfrey Pimundu, Annie Shonhai, Mutsa Bwakura-Dangarembizi, Alexander J Szubert

AIDS· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation.
Claire D Bourke, Ethan K Gough, Godfrey Pimundu, Annie Shonhai, Chipo Berejena, Alexander J Szubert

Sci Transl Med· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial.
Cissy Kityo, Alexander J Szubert, Abraham Siika, Robert Heyderman, Mutsa Bwakura-Dangarembizi

PLoS Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT.
Guy E Thwaites, Matthew Scarborough, Alexander Szubert, Pedro Saramago Goncalves, Marta Soares

Health Technol Assess· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rifampicin in treating S aureus bacteraemia - Authors' reply.
Guy E Thwaites, Alexander Szubert, A Sarah Walker

Lancet· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial.
Jane Mallewa, Alexander J Szubert, Peter Mugyenyi, Ennie Chidziva, Margaret J Thomason

Lancet HIV· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial.
Frank A Post, Alexander J Szubert, Andrew J Prendergast, Victoria Johnston, Hermione Lyall

Clin Infect Dis· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.
Guy E Thwaites, Matthew Scarborough, Alexander Szubert, Emmanuel Nsutebu, Robert Tilley

Lancet· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
Alexander J Szubert, Andrew J Prendergast, Moira J Spyer, Victor Musiime, Philippa Musoke

PLoS Med· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virologic Response to First-line Efavirenz- or Nevirapine-based Antiretroviral Therapy in HIV-infected African Children.
Adeodata Kekitiinwa, Alexander J Szubert, Moira Spyer, Richard Katuramu, Victor Musiime

Pediatr Infect Dis J· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy.
Andrew J Prendergast, Alexander J Szubert, Chipo Berejena, Godfrey Pimundu, Pietro Pala

J Infect Dis· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen.
Ruth M de Tute, Andy C Rawstron, Walter M Gregory, J Anthony Child, Faith E Davies, Alexander J Szubert

Haematologica· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis